Navigation Links
Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008

Breakthrough Innovation Gives Greater Numbers of Pharmaceutical Scientists Access to the Power of the Xevo TQ System's Quantitative and Qualitative


MILFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Focused on the process of helping firms to move promising drug candidates into commercialization, Waters Corporation (NYSE: WAT) will showcase innovative UltraPerformance LC(R) (UPLC) and mass spectrometry (MS) solutions at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), November 16 - 20 in Atlanta, Georgia.

With the cost of developing and commercializing new drugs at an all-time high, there is an acute need for versatile and multitasking analytical instruments that can automate routine tasks and obtain more analytical data faster with a minimum of effort. Waters(R) goal is to allow pharmaceutical scientists to devote more precious time to value-added, problem-solving activities that lie at the heart of the drug discovery process.

Leading Waters' offerings at AAPS is the Xevo(TM) TQ MS System, an advanced tandem quadrupole mass spectrometer that allows more pharmaceutical scientists across disciplines to quickly assess the candidacy of promising new entities. Aided by the instrument's IntelliStart(TM) and ScanWave(TM) technologies, the Xevo TQ MS System produces high-quality mass spectral data at UPLC(R) acquisition speeds without sacrificing data quality. With tools like the Xevo TQ MS System, increases in information per unit of time -- and in the value of that information -- promise to greatly enhance efforts to "industrialize" the process of drug discovery on a global basis.

Waters Scientific Seminars at AAPS

Waters UPLC and MS technologies have set new standards in resolution, sensitivity and speed of analysis. To demonstrate these capabilities, Waters will host one-hour educational seminars in Hall 4C, Aisle 100, on the following topics:

-- Developing Robust Quantitative Bioanalysis Methods with Innovations in


-- High-Sensitivity Qualitative and Quantitative LC/MS: New Possibilities

with an Easy-to use Tandem Quadrupole Mass Spectrometer

-- An Introduction to UPLC Technology

-- An Intelligent UPLC/TOF MS Workflow for Metabolite Identification

-- A Simple, Strategic Approach to Method Development

-- Maximizing Sensitivity and Flexibility in a Bioanalytical Assay with


Earlier this year the Xevo TQ MS System was recognized by Strategic Directions International's Instrument Business Outlook (IBO) newsletter when it selected the Xevo TQ MS System as the Best New Product at the 2008 American Society of Mass Spectrometry (ASMS) annual meeting in June:

"Since introducing the Xevo TQ MS System four months ago, the feedback we have received through customer demos has been outstanding," said Brian Smith, Vice President of Mass Spectrometry for the Waters Division. "Ranging from the impact of an 'intelligent' tandem quadrupole MS that automatically performs all those time consuming optimization steps normally performed manually by a skilled MS operator to the novel ScanWave technology that significantly enhances the quality of spectral data, mass spectrometer users at all levels are seeing the potential that the Xevo TQ MS System could bring to their laboratory."

Waters is now shipping the Xevo TQ MS System to customers on a worldwide basis.

For More Information

More information on Waters products at AAPS including the Synapt(TM) MS System and ACQUITY(R) UPLC System, visit Waters booth #2731 or go to: For information on the new Xevo TQ MS System visit For more information on Waters portfolio of LC/MS products, please visit:

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, Xevo, UltraPerformance LC, UPLC, ACQUITY, Synapt, ScanWave, and IntelliStart are trademarks of Waters Corporation.


Brian J. Murphy

Waters Corporation

Public Relations Manager


SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts
2. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
3. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
4. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
5. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
6. 2007: A Watershed Year for Lupus Research and Education
7. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
8. Waters Corporation Receives Market Leadership and Product Innovation Awards
9. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
10. Cleveland Clinic Unveils Top 10 Medical Innovations for 2009
11. Coromega Unveils New Healthy Heart and CoQ10 Supplements : Revolutionary Omega-3 Supplement Company Introduces Two Fresh Takes on Heart Health and Antioxidants
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: